Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatocyte apoptosis and injury refer to processes by which liver parenchymal cells die or are damaged via intrinsic (mitochondrial/caspase-mediated) or extrinsic (death receptor) pathways. Apoptosis in hepatocytes can be triggered by various insults, including toxins, immune responses, and metabolic disturbances, and contributes to inflammation, fibrosis, and the progression of liver diseases such as NASH and hepatocellular carcinoma. Apoptosis and necrosis are often concentration-dependent and can coexist; excessive apoptosis drives compensatory proliferation and can promote tumorigenesis. Key molecular mediators include the caspase family, BCL-2 family proteins, death receptors (e.g., TRAIL, TNF receptors), mitochondrial permeabilization, and regulatory kinases. Therapeutic inhibitors or modulators of these pathways are under investigation for modifying liver injury outcomes.
Caspase inhibition (blocks apoptosis); Necroptosis inhibition (e.g., necrostatin-1); Mitochondrial protection
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatocyte apoptosis and injury.